| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5197323
Max Phase: Preclinical
Molecular Formula: C20H29N5O4S
Molecular Weight: 435.55
Associated Items:
Representations
Canonical SMILES: CCc1c(-c2csc(N3CCNCC3C(=O)NC(CO)CO)n2)[nH]c(C)c1C(C)=O
Standard InChI: InChI=1S/C20H29N5O4S/c1-4-14-17(12(3)28)11(2)22-18(14)15-10-30-20(24-15)25-6-5-21-7-16(25)19(29)23-13(8-26)9-27/h10,13,16,21-22,26-27H,4-9H2,1-3H3,(H,23,29)
Standard InChI Key: OHGZRFBKZRICMV-UHFFFAOYSA-N
Associated Targets(Human)
BAZ2A Tchem Bromodomain adjacent to zinc finger domain protein 2A (266 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 435.55 | Molecular Weight (Monoisotopic): 435.1940 | AlogP: 0.46 | #Rotatable Bonds: 8 |
| Polar Surface Area: 130.58 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 5 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.68 | CX Basic pKa: 7.96 | CX LogP: 0.42 | CX LogD: -0.24 |
| Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.38 | Np Likeness Score: -0.79 |
References
| 1. Dalle Vedove A, Cazzanelli G, Batiste L, Marchand JR, Spiliotopoulos D, Corsi J, D'Agostino VG, Caflisch A, Lolli G.. (2022) Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing., 13 (9.0): [PMID:36105334] [10.1021/acsmedchemlett.2c00173] |
Source
Source(1):